W
William E. Boden
Researcher at University at Buffalo
Publications - 106
Citations - 9104
William E. Boden is an academic researcher from University at Buffalo. The author has contributed to research in topics: Coronary artery disease & Medicine. The author has an hindex of 30, co-authored 70 publications receiving 8249 citations. Previous affiliations of William E. Boden include Hartford Hospital & University of Connecticut.
Papers
More filters
Journal ArticleDOI
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
William E. Boden,Koon K. Teo,Pamela M. Hartigan,David J. Maron,William J. Kostuk,Merril L. Knudtson,Marcin Dada,Paul Casperson,Crystal L. Harris,Bernard R. Chaitman,Leslee J. Shaw,Gilbert Gosselin,Shah Nawaz,Lawrence M. Title,Gerald T. Gau,Alvin Blaustein,David C. Booth,Eric R. Bates,John A. Spertus,Daniel S. Berman,William S. Weintraub +20 more
TL;DR: As an initial management strategy in patients with stable coronary artery disease, PCI did not reduce the risk of death, myocardial infarction, or other major cardiovascular events when added to optimal medical therapy.
Journal ArticleDOI
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
Leslee J. Shaw,Daniel S. Berman,David J. Maron,G.B. John Mancini,Sean W. Hayes,Pamela M. Hartigan,William S. Weintraub,Robert A. O'Rourke,Marcin Dada,John A. Spertus,Bernard R. Chaitman,John D. Friedman,Piotr J. Slomka,Gary V. Heller,Guido Germano,Gilbert Gosselin,Peter B. Berger,William J. Kostuk,Ronald G. Schwartz,Merill L Knudtson,Emir Veledar,Eric R. Bates,Benjamin D. McCallister,Koon K. Teo,William E. Boden +24 more
TL;DR: In COURAGE patients who underwent serial MPS, adding PCI to OMT resulted in greater reduction in ischemia compared with OMT alone, and the findings suggest a treatment target of ≥5% ischemic myocardium reduction with O MT with or without coronary revascularization.
Journal ArticleDOI
Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative
Deepak L. Bhatt,Matthew T. Roe,Eric D. Peterson,Yun Li,Anita Y. Chen,Robert A. Harrington,Adam Greenbaum,Peter B. Berger,Christopher P. Cannon,David J. Cohen,C. Michael Gibson,Jorge F. Saucedo,Neal S. Kleiman,Judith S. Hochman,William E. Boden,Ralph G. Brindis,W. Frank Peacock,Sidney C. Smith,Charles V. Pollack,W. Brian Gibier,E. Magnus Ohman +20 more
TL;DR: An early invasive management strategy appears to be reserved for patients without significant comorbidities and those cared for by cardiologists and is associated with a lower risk of in-hospital mortality.
Journal ArticleDOI
Optimal medical therapy with or without PCI for stable coronary disease
TL;DR: This study highlights the need to understand more fully the rationale behind the continued use of EMT in women with high blood pressure and also investigates its applications in the context of chronic pain.
Journal ArticleDOI
Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease.
Abstr Act,Steven P. Sedlis,Pamela M. Hartigan,Koon K. Teo,David J. Maron,John A. Spertus,William J. Kostuk,Bernard R. Chaitman,Daniel S. Berman,Jeffrey D. Lorin,Marcin Dada,William S. Weintraub,William E. Boden +12 more
TL;DR: During an extended-follow-up of up to 15 years, there did not find a difference in survival between an initial strategy of PCI plus medical therapy and medical therapy alone in patients with stable ischemic heart disease.